96740 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids
Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1502Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1503Methods of treating chronic and neuropathic pain mediated by N-type neuronal calcium channels using D-enantiomeric peptides
#1504Methods and compositions for refining molybdenum mineral
#1505ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHODS OF USE THEREOF
#1506Engineered potent cytotoxic stapled BH3 peptides
#1507Extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies
#1508Modulators of melanocortin receptors
#1509PROCESS FOR PREPARATION OF ICATIBANT ACETATE
#1510Linker molecule and use thereof in methods for purifying peptides
#1511Heterotandem bicyclic peptide complexes
#1512Universal kinase substrates and methods of use thereof
#1513Lytic peptide biosensor and methods of making and using the same
#1514METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF USING NCAM PEPTIDE MIMETICS
#1515Selectin inhibitors, composition, and uses related thereto
#1516Solution-phase affinity selection of inhibitors from combinatorial peptide libraries
#1517LYTIC PEPTIDE BIOSENSOR AND METHODS OF MAKING AND USING THE SAME
#1518Anti-inflammatory nanofibers
#1519HUMAN MYOSIN PEPTIDES
#1520Anticancer peptides
#1521Peptide, fluorescent probe comprising the same, and preparation method thereof
#1522SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION
#1523Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#1524Antimicrobial peptoids with improved selectivity and use thereof
#1525BIFUNCTIONAL PEPTIDE HAVING CAPABILITY TO REDUCE INFLAMMATION AND CAPABILITY TO FACILITATE DIFFERENTIATION OF STEM CELLS INTO CHONDROCYTES AND USE THEREOF
#1526Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
#1527Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
#1528PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS
#1529NOVEL ULK1 INHIBITORS AND METHODS USING SAME
#1530Hemagglutinin-binding peptide
#1531Di-sulfide containing cell penetrating peptides and methods of making and using thereof
#1532Antimicrobial peptides comprising epsilon lysine residues
#1533FoxP3-binding peptides and uses thereof
#1534EBOLA VIRUS VACCINE
#1535Kinase and/or phosphatase sensing via hydroxyquinoline-sensitized chelates
#1536Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)
#1537Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#1538Compositions and methods for cell delivery
#1539Method of facilitating the bindings between keratinocytes
#1540Method of predicting progression of idiopathic pulmonary fibrosis and monitoring of therapeutic efficacy
#1541Immunogenic WT-1 peptides and methods of use thereof
#1542Peptides derived from the propeptide NTSR3 and their use in the treatment of depression
#1543Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
#1544Peptides and combination of peptides for use in immunotherapy against various cancers
#1545TAU PEPTIDES, METHODS OF MAKING, AND METHODS OF USING
#1546Multimeric bicyclic peptide ligands
#1547Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor
#1548Agonists of guanylate cyclase and their uses
#1549Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers
#1550Peptides and combination of peptides for use in immunotherapy against various cancers
#1551COMPOSITIONS USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
#1552Detection and treatment of demyelinating diseases
#1553Immunotherapy compositions and methods
#1554PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF
#1555High affinity CXCR4 selective binding conjugate and method for using the same
#1556Butyrylcholinesterase zwitterionic polymer conjugates
#1557GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#1558Fc FUSION PROTEINS COMPRISING NOVEL LINKERS OR ARRANGEMENTS
#1559NOVEL a4ß7 PEPTIDE DIMER ANTAGONISTS
#1560Compositions comprising PEDF-derived short peptides and uses thereof
#1561Cell-permeable (CP)-Δ SOCS3 recombinant protein and uses thereof
#1562Cell-penetrating compstatin analogs and uses thereof
#1563DNA primase and gyrase inhibitors
#1564ULK1 inhibitors and methods using same
#1565ICAM-1 TARGETING ELPS
#1566MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#1567Novel Promiscuous HPV16-Derived T Helper Epitopes for Immunotherapy
#1568Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof
#1569CYCLIC PEPTIDE INHIBITORS OF HEDGEHOG PROTEINS
#1570Structure-based peptide inhibitors of alpha-synuclein aggregation
#1571Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment
#1572ANTI HLA-G SPECIFIC ANTIBODIES
#1573Method of synthesizing antagonist peptides for cell growth
#1574Antimicrobial peptides based on CMAP27
#1575Polypeptide ligands specific for plasma kallikrein
#1576Synthetic lipopeptide vaccines and immunotherapeutics
#1577Therapeutic multi-targeting constructs and uses thereof
#1578METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS
#1579Agents that activate CD47 and their use in the treatment of inflammation
#1580Biologically active peptides
#1581Fusion protein, polynucleotide, genetic construct, producer, preparation for regeneration of cartilage
#1582METHODS AND COMPOSITIONS FOR TARGETING PROGENITOR CELL LINES
#1583Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1584Therapeutic spalt-like transcription factor 4 (SALL4) peptide
#1585COMPOSITIONS FOR AND METHODS OF TREATING AND PREVENTING CANCER TARGETING TUMOR ASSOCIATED CARBOHYDRATE ANTIGENS
#1586ACTH PROPHYLACTIC TREATMENT OF RENAL DISORDERS
#1587Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#1588PROTEIN INTERFACES
#1589PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES
#1590Production of highly thermally stable recombinant cholinesterases for the detection, detoxification and decontamination of organophosphorus compounds
#1591Modified proteins and methods of use thereof
#1592Magnetic particle-binding peptides
#1593Targeting dimerization of BAX to modulate BAX activity
#1594Stapled and stitched polypeptides and uses thereof
#1595Peptide having anticancer activity, and pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and treating cancer comprising the same as active ingredient
#1596Influenza peptides and compositions
#1597Compositions and methods for the treatment of neurodamage
#1598MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
#1599Solid state forms of linaclotide
#1600Compositions and methods for modulating γ-c-cytokine activity
#1601Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods
#1602THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
#1603Polypeptide exhibiting affinity to antibodies forming non-native three-dimensional structure
#1604SOLID PHASE PEPTIDE SYNTHESIS
#1605Conjugate of minoxidil and peptide
#1606TLR9 targeted therapeutics
#1607Anti-inflammatory peptides and compositions comprising the same
#1608Bicyclic peptide ligands specific for EphA2
#1609Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells
#1610Methods and compositions comprising a C-terminal Bax peptide
#1611FC RECEPTOR (FcRn) BINDING PEPTIDES AND USES THEREOF
#1612Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
#1613Fusion protein comprising apelin and an anti-APLNR antibody
#1614Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1615Peptide or pharmaceutically acceptable salt thereof, or prodrug thereof
#1616Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1617Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1618Chloride salt of TAT-NR2B9c
#1619antigens
#1620Immunotherapy methods using anti-PD-L1 antibodies in combination with EGFR1 targeted-TGF-beta immunomodulatory fusion proteins
#1621Peptide inhibitors of phosphoglycerate mutase and methods of use
#1622Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1623C1q and HMGB1 fusion proteins and uses thereof
#1624Nucleic acid condensing peptide, nucleic acid condensing peptide set, nucleic acid delivery carrier, nucleic acid delivery method, cell production method, cell detection method and kit
#1625Pharmaceutical composition and the use thereof in the treatment of autoimmune diseases
#1626Bone fracture repair by targeting of agents that promote bone healing
#1627Ultra bright polymeric dyes with peptide backbones
#1628Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#1629Plant-derived elastin binding protein ligands and methods of using the same
#1630PEPTIDE INHIBITORS OF CALCIUM OXALATE MONOHYDRATE CRYSTALLIZATION AND USES THEREOF
#1631Antibacterial sideromycins
#1632ULK1 inhibitors and methods using same
#1633Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#1634Method for treating or/and preventing calcium deficiency-related diseases
#1635PLIF MULTIMERIC PEPTIDES AND USES THEREOF
#1636Peptides of syndecan-1 for inhibiting angiogenesis
#1637Peptide having effects of increasing telomerase activity and extending telomere, and composition containing same
#1638Chemosynthetic cyclo-hepta modified peptide capable of inhibiting toxin of and use thereof
#1639Reagents and methods for detecting protein crotonylation
#1640Methods and systems for designing and/or characterizing soluble lipidated ligand agents
#1641Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
#1642Bicyclic peptide-toxin conjugates specific for MT1-MMP
#1643TFPI inhibitors and methods of use
#1644Device for biological material detection, detection apparatus for biological material detection, method for measuring ion current, and method for identifying biological material
#1645Methods to specifically profile protease activity at lymph nodes
#1646COMPOSITIONS AND METHODS FOR TISSUE REPAIR
#1647Methods of treatment using activatable anti-EGFR antibodies
#1648Ras binding peptides and methods of use
#1649PAR3 mimetic peptides and uses thereof
#1650PEPTIDES AND NANOPARTICLE FORMULATIONS THEREOF
#1651Modulation of complement activity
#1652Selective delivery molecules and methods of use
#1653CYCLIN A1-TARGETED T-CELL IMMUNOTHERAPY FOR CANCER
#1654CNP CYCLIC PEPTIDE, AND MEDICINE, EXTERNAL PREPARATION AND COSMETIC EACH CONTAINING SAID CYCLIC PEPTIDE
#1655Peptide showing melanin generation-promoting activity and use thereof
#1656NEW NUCLEOPHILE-REACTIVE SULFONATED COMPOUNDS FOR THE (RADIO)LABELLING OF (BIO)MOLECULES; PRECURSORS AND CONJUGATES THEREOF
#1657PET-imaging immunomodulators
#1658Inhibition of TREM receptor signaling with peptide variants
#1659Peptidic TGF-beta antagonists
#1660Peptide for skin regeneration or wound treatment and use thereof
#1661Diarylsulfide backbone containing photolabile protecting groups
#1662Sterilization and filtration of peptide compositions
#1663Polyethylene glycol-modified angiogenesis inhibitor HM-1 and application thereof
#1664Peptide with ability to penetrate cell membrane
#1665BINDING INHIBITORS OF THE BETA. TRANSDUCIN REPEAT-CONTAINING PROTEIN
#1666Neurodegenerative disorders
#1667SIGNAL BIOMARKERS
#1668PROTRANSDUZIN B, A GENE TRANSFER ENHANCER
#1669Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1670Peptide exhibiting hair growth promoting activity and/or melanin production promoting activity and use thereof
#1671CHIMERIC POLYPEPTIDES AND USES THEREOF
#1672Stapled peptides and uses thereof
#1673Peptide
#1674Immunogenic WT-1 peptides and methods of use thereof
#1675Cyclic peptide conjugates and methods of use
#1676Amphipathic peptide
#1677Amidated Dopamine Neuron Stimulating Peptides for CNS Dopaminergic Upregulation
#1678Material and method to screen proteasome stimulators
#1679D-enantiomeric peptides derived from D3 and use thereof
#1680CYCLIN-DEPENDENT KINASE 5 (CDK5) INHIBITORY PEPTIDES
#1681Synthetic peptides that modulate the NMDA receptor
#1682Synthetic compound for improving efficiency of transfection
#1683Peptides with anti-cancer activity
#1684Compstatin analogs with improved pharmacokinetic properties
#1685Cell penetrating peptides for intracellular delivery of molecules
#1686Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers
#1687Connective tissue stimulating peptides
#1688Immunogenic rhinovirus peptides
#1689Immunotherapy against neuronal and brain tumors
#1690Immunotherapy against neuronal and brain tumors
#1691ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF
#1692PEPTIDE INHIBITORS OF SODIUM CHANNELS
#1693Activated polyoxazolines and conjugates and compositions comprising the same
#1694Modulating gamma-c-cytokine activity
#1695Compositions and methods for reducing ice crystal formation
#1696Method for determining the cell mediated immune competence of a subject
#1697Polypeptide inhibitors of SMAD3 polypeptide activities
#1698Composition and Method for Therapeutic Agent Delivery During Pregnancy
#1699Treatments for Gastrointestinal Disorders
#1700Composition for overcoming resistance to EGFR-targeting agent
#1701METHOD OF GENERATING INTERACTING PEPTIDES
#1702KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING THE SAME
#1703Therapeutic inhibitor for EBV-associated tumor with tailor responsive optical imaging
#1704METHOD OF DETECTING AUTO-ANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS, A PEPTIDE AND ASSAY KIT
#1705Polypeptide, DNA molecule encoding the polypeptide, vector, preparation method and use
#1706Skin-penetrating peptide and method for using same
#1707PROCESS FOR THE PREPARATION OF GUANYLATE CYCLASE 2C AGONIST
#1708METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#1709Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant P53
#1710ANTI-MICROBIAL PEPTIDES AND COATINGS
#1711Albumin binding peptide conjugates and methods thereof
#1712Cell penetrating peptides for intracellular delivery of molecules
#1713LABYRINTHOPEPTINS AS ANTI-VIRAL AGENTS
#1714Methods of treating acute myeloid leukemia
#1715Peptides Having Anti-Inflammatory Properties
#1716Proteinaceous compounds and uses therefor
#1717EPHA4 cyclic peptide antagonists for neuroprotection and neural repair
#1718Method for treating blood, blood products and organs
#1719Methods for delivering cargo into a cell by using signal molecules as cell penetration agents
#1720WT1 antigen peptide conjugate vaccine
#1721Anti-inflammatory peptides and composition comprising the same
#1722Peptide tag and tagged protein including same
#1723EPHA2 t-cell epitope agonists and uses therefore
#1724Compositions and methods of using islet neogenesis peptides and analogs thereof
#1725D-peptide inhibitors of HIV entry and methods of use
#1726Peptide exhibiting hydrolytic activity and use thereof
#1727Peptides for targeting gastric cancer, and medical use tehreof
#1728Potent Compstatin Analogs
#1729Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof
#1730α4β7 thioether peptide dimer antagonists
#1731Peptides and combination of peptides for use in immunotherapy against various cancers
#1732Derivative Peptide Compounds and Methods of Use
#1733Polypeptide expressed in the stratum corneum and use thereof
#1734NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
#1735Fragments of P97 and uses thereof
#1736Circular tandem repeat proteins
#1737Peptide and use thereof
#1738Immunotherapy against several tumors, such as lung cancer, including NSCLC
#1739ANALOGUES OF HEPCIDIN MIMETICS WITH IMPROVED IN VIVO HALF LIVES
#1740Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders
#1741Ultra-pure agonists of guanylate cyclase C, method of making and using same
#1742NOVEL a4B7 PEPTIDE DIMER ANTAGONISTS
#1743Peptides and nanoparticles for intracellular delivery of molecules
#1744Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity
#1745Manganese-based chelate conjugates for molecular MR imaging
#1746NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#1747Bladder cancer biomarker proteins
#1748ANTIBODIES AGAINST IMMUNOGENIC GLYCOPEPTIDES, COMPOSITIONS COMPRISING THE SAME AND USE THEREOF
#1749Therapeutic DLL4 Binding Proteins
#1750Murine anti-NY-ESO-1 T cell receptors
#1751Linaclotide synthesis method
#1752Bicyclic peptide ligands with detectable moieties and uses thereof
#1753Modulation of complement activity
#1754POLYPEPTIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF
#1755Nucleic acid nanocapsules for drug delivery and targeted gene knockdown
#1756Dietary peptides
#1757Protein detection method, and protein immunoassay method
#1758Adhesive molecules
#1759Compositions and Methods for Inhibiting CBP80 Binding to PGC1 Family of Co-Activators
#1760Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions
#1761Modulation of structured polypeptide specificity
#1762Peptides that target inflamed or distressed cardiac tissue and uses related thereto
#1763LIPIDATED STREPTOCOCCUS PNEUMONIAE ANTIGEN COMPOSITIONS, METHODS OF PREPARATION AND USE
#1764Peptides and combination of peptides for use in immunotherapy against various cancers
#1765Peptides and combination of peptides for use in immunotherapy against various cancers
#1766Peptide having highly-shifted accumulation to pancreatic cancer cells and tissues, and use of said peptide
#1767METHODS AND MATERIALS FOR GENERATING T CELLS
#1768Cyclic NTCP-targeting peptides and their uses as entry inhibitors
#1769Biosynthetic proline/alanine random coil polypeptides and their uses
#1770Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1771Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1772Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1773Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1774PEPTIDES
#1775Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
#1776ANTI-TUMOUR RESPONSE TO MODIFIED SELF-EPITOPES
#1777Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#1778Peptides having antimicrobial activity and new enzyme capable of converting L-configured residue in D-configured amino acid in a peptide
#1779PEPTIDES
#1780Peptides and uses therefor as antiviral agents
#1781METHOD FOR OBTAINING TUMOR PEPTIDES AND USES THEREOF
#1782Peptides derived from transient receptor potential cation channel subfamily M member 1 (TRPM1), complexes comprising such peptides bound to MHC molecules
#1783Peptide composition
#1784Pharmaceutical composition for injection
#1785Peptides and combination of peptides for use in immunotherapy against CLL and other cancers
#1786Neuroprotective peptides derived from activity-dependent neuroprotective protein for treatment of neurological diseases
#1787Transfection complexes and methods of using the same
#1788METHODS AND COMPOSITIONS RELATED TO IMPROVING PROPERTIES OF PHARMACOLOGICAL AGENTS TARGETING NERVOUS SYSTEM
#1789PD-1 and CTLA-4 dual inhibitor peptides
#1790Broken or folded helical peptide or peptide analog exhibiting antimicrobial activity against gram-negative bacteria, and use thereof
#1791PEPTIDOMIMETIC MACROCYCLES
#1792Collagenase-derived peptides promote tissue regeneration and wound healing
#1793Anti-hepatitis B virus X protein polypeptide pharmaceutical
#1794NPR-B agonists
#1795Antisense composition and method for treating muscle atrophy
#1796Surfactant adhesive composition
#1797Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers
#1798Peptides
#1799Selenium-based therapies
#1800Purification method, purification kit, and silicon oxide-binding tag for use therein